Gamma-Tocotrienol Is Required for Normal Vitamin D Metabolism in Female Rats

Total Page:16

File Type:pdf, Size:1020Kb

Gamma-Tocotrienol Is Required for Normal Vitamin D Metabolism in Female Rats Research Paper Gamma-tocotrienol is required for normal vitamin D metabolism in female rats M. Norazlina, F.W. Ng*, S. Ima-Nirwana ABSTRACT Objective: To study the effects of vitamin E deficiency and supplementation of vitamin Dept of Pharmacology, D and bone metabolism in female Sprague-Dawley rats. Faculty of Medicine & *Dept of Biomedical Sciences, Materials and Methods: Rats weighing between 200 and 250 g were divided into six Faculty of Allied Health Sciences, groups, that is, rats fed on (a) normal rat chow diet (RC), (b) vitamin E–deficient diet Universiti Kebangsaan Malaysia, (VED) (c) VED diet supplemented with 60 mg/kg α-tocopherol acetate (ATF), (d) VED Kuala Lumpur, Malaysia. diet supplemented with 60 mg/kg γ-tocotrienol (GTT), (e) VED diet supplemented with 60 mg/kg Tocomin® (TOC) and (f) baseline control group which was killed without Received: 24.2.2005 treatment (BC). Treatment was given for 2 months. Serum 1,25-dihydroxyvitamin D3, Revised: 24.8.2005 serum total calcium, urine calcium, left femur, and fourth lumbar vertebra calcium Accepted: 31.8.2005 content and left femur length were measured. Results: In the VED and ATF groups, activation of vitamin D to 1,25-dihydroxyvitamin Correspondence to: D was inhibited and calcium reabsorption in the kidneys were increased. Both the Ima Nirwana Soelaiman 3 Department of Pharmacology, effects seen in ATF and GTT groups were observed in the TOC group. The GTT group Faculty of Medicine, was protected from the effects of the vitamin E–deficient diet. Calcium content of the Universiti Kebangsaan Malaysia, fourth lumbar vertebra was also decreased by vitamin E– deficiency, which was not Jalan Raja Muda Abdul Aziz reversed by vitamin E supplementation. 50300 Kuala Lumpur, Malaysia. Conclusion: γ-tocotrienol and not α-tocopherol protects vitamin D metabolism and E-mail: [email protected] calcium homeostasis from the effects of vitamin E–deficiency. KEY WORDS: Calcium homeostasis, α-tocopherol, vitamin E–deficiency. Introduction postmenopausal women.[5] Tocotrienol was shown to reduce Vitamin D and its metabolites are among the factors that carcinogenesis,[6] and to inhibit the production of HMG-CoA reductase – the enzyme responsible for cholesterol synthesis.[7] are important in regulating bone metabolism. Vitamin D3 is a prohormone, which is hydroxylated in the liver and in the kidney Palm oil is the major source of vitamin E, mainly the tocotrienol type. Vitamin E–rich extract from palm oil protected to the active metabolite 1,25-dihydroxyvitamin D3 and 24,25- the bone against the toxic effects of the oxidizing agent ferric dihydroxyvitamin D3. In a previous study, supplementation with nitrilotriacetate,[8] reduced bone resorption, and increased the α 1, 25-dihydroxyvitamin D3 analogue was able to increase bone mineral density in osteoporotic women.[1] The most potent survival rate of thyrotoxic rats[9] and prevented the decline in bone mineral density, and bone calcium loss seen in vitamin D metabolite is 1,25-dihydroxyvitamin D3 (calcitriol), which stimulates calcium and phosphate transport from the orchidectomized rats.[10] intestine and calcium reabsorption from bone.[2] 1,25- Palm vitamin E (60 mg/kg) was comparable to α-tocopherol dihydroxyvitamin D3 has also been reported to act directly on in maintaining bone mineral density and bone calcium content circulating osteoclast precursors to influence osteoclast in ovariectomized rats.[11] Tocotrienols and δ-tocopherol were differentiation.[3] able to induce apoptosis in human mammary gland tumor Vitamin E, a lipid-soluble vitamin with antioxidant cells.[12] However, a few studies found that tocotrienol is properties has an important role in protecting biological superior compared to tocopherol. Alpha-tocotrienol was able systems. There are two types of vitamin E; tocopherol and to protect against glutamate-induced neuron cell death tocotrienol, and there are 4 isomers for each type: alpha (α), compared to α-tocopherol.[13] Palm vitamin E improved bone beta (β), gamma (γ) and delta (δ). Tocopherol has been shown calcium content in vitamin E– deficient rats compared to α- to prevent lipid peroxidation[4] and heart disease in tocopherol.[14] Indian J Pharmacol | October 2005 | Vol 37 | Issue 5 | 309-314 309 Norazlina et al. Vitamin E deficiency impaired calcification[15] and retarded Table 1 bone growth[16] in normal and ovariectomized rats. Its mechanism is unclear. One hypothesis is that vitamin E Rat Chow diet composition (Gold Coin, Malaysia) deficiency may influence the hormones regulating bone Composition Amount/Percentage metabolism (e.g., vitamin D metabolism). Other studies have Crude protein 21-23% shown that the presence of vitamin E is crucial in vitamin D Soybean meal metabolism and calcium absorption from the intestines in Skimmed milk powder which they found that vitamin E deficiency reduced calcium absorption from the intestines[17] and inhibited the conversion Crude fibre (max.) 5.0% of vitamin D to its active metabolites.[18] To further examine Crude fat (min.) 3.0% this hypothesis, this study was carried out, in which the effects Crude palm oil of a vitamin E–deficient diet on vitamin D metabolism and Moisture (max.) 3.0% bone calcium homeostasis were determined. The effects of Calcium 0.8-1.2% supplementation with three different types of vitamin E on Phosphorus 0.6-1.0% vitamin D metabolism were also studied. Nitrogen free extract (approx.) 49.0% Materials and Methods Additives per metric tonne of feed (approx.) Animals and treatment Vitamin A 10 M.I.U. Three-month old female Sprague-Dawley rats weighing 200 Vitamin D3 2.5 M.I.U. to 250 g, obtained from the University Breeding Centre, were Vitamin E 15 g used. This study was a continuation of our previous study which Vitamin K trace Vitamin B trace used female rats, and for this study the gender of the animals 12 was maintained. The rats were divided into 6 groups of 10 Thiamine trace each: (1) control group fed normal rat chow diet (RC), and Riboflavin trace treatment groups fed with (2) vitamin E–deficient diet (VED), Pantothenic acid trace (3) vitamin E–deficient diet supplemented with 60 mg/kg pure Niacin trace Pyridoxine trace α-tocopherol acetate (ATF), (4) vitamin E–deficient diet sup- Choline trace plemented with 60 mg/kg γ-tocotrienol (GTT) and (5) vitamin E–deficient diet supplemented with 60 mg/kg Tocomin® (TOC). Antioxidants per metric tonne of feed The respective diets were given ad libitum. Treatment was Santoquin 125 g carried out for 2 months. The sixth group, which acts as base- Microminerals trace line control (BC), was untreated and was killed at the begin- Iron ning of the study (day zero). This group acts as the control for Cobalt bone calcium content and femur length. The other parameters Manganese were measured in either the serum or urine. For control val- Iodine ues of these parameters, blood and urine were collected from Selenium each treatment group at day zero. Five rats were kept per cage under 12 h natural light/dark cycles and given distilled Serum was stored at –700C for the measurement of 1,25- water ad libitum. dihydroxyvitamin D3 and calcium. Diets At the end of the treatment period, the rats were Normal rat chow was obtained from Gold Coin, Port Klang, anesthetized and then sacrificed. Left femoral and 4th lumbar Selangor, Malaysia. Vitamin E–deficient diet and α-tocopherol bones were dissected out and cleansed of all soft tissues. acetate were purchased from ICN Biomedicals, Costa Mesa, Femur length was measured and the bones were then stored CA, USA. The composition of rat chow diet and vitamin E– at –700C for the measurement of bone calcium content. deficient diet are shown in Table 1 and 2, respectively. Gamma- Urine collection tocotrienol, which contains 82% γ-tocotrienol, and Tocomin® Urine samples were collected before the start of treatment were supplied by Carotech Sdn Bhd, Ipoh Perak, Malaysia. and at the end of the treatment period. For this purpose, rats Tocomin® contains 22.1% γ-tocotrienol, 6.8% δ-tocotrienol, were placed in individual metabolic cages beginning at 4 o’clock 10.7% α-tocotrienol, and 11.5% α-tocopherol. Vitamin E was in the afternoon until 8 o’clock the next morning. Urine excreted dissolved in olive oil, produced by Bertolli Classico, Italy. during that period was collected and centrifuged at 3000 rpm Alpha-tocopherol (60 mg/kg, body weight) was prepared for 10 min at 40C. Hydrochloric acid 6M was added to the by mixing 3 g of α-tocopherol in 47 g olive oil. The same supernatant obtained until the final pH of the urine was less procedure was applied in preparing γ-tocotrienol and Tocomin® than 2.0 to dissolve the calcium ions in the urine. (60 mg/kg, b.w.). 0.1 mL/100 g rat weight of the respective Serum 1,25-dihydroxyvitamin D3 level solutions was given by oral gavage 6 days a week for 2 months. Measurement was carried out using the ELISA kit from Bone and blood samples collection ImmunDiagnostik, Germany (catalog no. K2112). Color Blood samples were taken before the start of treatment intensity, which reflects 1,25-dihydroxyvitamin D3 and at the end of treatment period. The rats were anesthetized concentration, was determined by using an ELISA reader with diethyl ether and blood was taken via the orbital sinus. (Tecan Spectra Classic, Austria). 310 Indian J Pharmacol | October 2005 | Vol 37 | Issue 5 | 309-314 Vitamin E deficiency on vitamin D and calcium homeostasis Table 2 Serum and urine calcium levels Total serum and urine calcium levels were measured on Vitamin E–deficient diet composition (Draper et al) the basis of the complex produced because of the reaction Composition Fraction/Percentage between calcium and complexion o-cresol phthalein.
Recommended publications
  • Dispensing of Vitamin Products by Retail Pharmacies in South Africa: Implications for Dietitians
    South African Journal of Clinical Nutrition 2016; 29(4):133–138 http://dx.doi.org/10.1080/16070658.2016.1219468 SAJCN ISSN 1607-0658 EISSN 2221-1268 Open Access article distributed under the terms of the © 2016 The Author(s) Creative Commons License [CC BY-NC 3.0] http://creativecommons.org/licenses/by-nc/3.0 RESEARCH Dispensing of vitamin products by retail pharmacies in South Africa: Implications for dietitians Ilse Trutera* and Liana Steenkampb a Department of Pharmacy, Drug Utilisation Research Unit (DURU), Nelson Mandela Metropolitan University, Port Elizabeth, South Africa b HIV & AIDS Research Unit, Nelson Mandela Metropolitan University, Port Elizabeth, South Africa *Corresponding author, email: [email protected] Objective: The objective of this study was to analyse the dispensing patterns of vitamins (Anatomical Therapeutic Chemical (ATC) group A11) over a one-year period in a group of community pharmacies in South Africa. Design and setting: A retrospective drug utilisation study was conducted on community pharmacy electronic dispensing records in South Africa recorded in 2013. Outcome measures: All products for ATC subgroup A11 were extracted and analysed. Results: A total of 164 233 vitamin products were dispensed to 84 805 patients (62.64% female patients). Males received on average 2.09 (SD = 2.63) vitamin products per year, compared to 1.84 (SD = 2.13) products for females. Ergocalciferol (A11CC01) was the most often dispensed (37.48% of all vitamin products), followed by plain Vitamin B-complex products (A11EA00) accounting for 32.77%. Ergocalciferol (vitamin D2) is only available on prescription (50 000 IU tablets or 50 000 IU/ml oily drops) in South Africa.
    [Show full text]
  • Report on Effects of Beta-Carotene Supplementation in Combination with Tocopherol and Ascorbate in Clinical and Chemopreventive Trials (Adopted by the SCF on 19/3/98)
    Report on Effects of Beta-carotene Supplementation in Combination with Tocopherol and Ascorbate in Clinical and Chemopreventive Trials (Adopted by the SCF on 19/3/98) Terms of Reference The committee was asked by the Commission to review on recent reports of the studies on health effects of high doses of beta-carotene, retinol and alpha-tocopherol as well as ascorbate in controlled studies. Introduction Epidemiological studies of the last ten years have indicated that beta-carotene is a potential agent for the chemical prevention against carcinogenesis. In contrast, the recent prospective study performed by Heinonen et al. (1) has strikingly suggested that supplementation with beta-carotene significantly increased the incidence of lung, prostate and stomach cancer. The rising question is the possible dose dependency of a preventive or harmful action of beta-carotene and possible synergistic effects with other antioxidants. To answer this question clinical trials for therapy and intervention studies in healthy populations dealing with beta- carotene supplementation in different dosages below the GRAS daily intake of 200 mg have to be regarded. Clinical trials Therapeutic dosages of beta-carotene applied varied in a relative wide range of 20 mg/d to 180 mg/d. The highest daily dosage of 180 mg beta-carotene in combination with 100.000 IU vitamin A ( 30 mg retinol equivalents) was applied 1988 by Stich et al. (2) in tobacco chewers who had already sustained premalignant leukoplakia. After 6 months the single treatment with beta-carotene induced a significant remission of leukoplakias compared to the placebo group, although the combination of beta-carotene and retinol was much more effective.
    [Show full text]
  • Guidelines on Food Fortification with Micronutrients
    GUIDELINES ON FOOD FORTIFICATION FORTIFICATION FOOD ON GUIDELINES Interest in micronutrient malnutrition has increased greatly over the last few MICRONUTRIENTS WITH years. One of the main reasons is the realization that micronutrient malnutrition contributes substantially to the global burden of disease. Furthermore, although micronutrient malnutrition is more frequent and severe in the developing world and among disadvantaged populations, it also represents a public health problem in some industrialized countries. Measures to correct micronutrient deficiencies aim at ensuring consumption of a balanced diet that is adequate in every nutrient. Unfortunately, this is far from being achieved everywhere since it requires universal access to adequate food and appropriate dietary habits. Food fortification has the dual advantage of being able to deliver nutrients to large segments of the population without requiring radical changes in food consumption patterns. Drawing on several recent high quality publications and programme experience on the subject, information on food fortification has been critically analysed and then translated into scientifically sound guidelines for application in the field. The main purpose of these guidelines is to assist countries in the design and implementation of appropriate food fortification programmes. They are intended to be a resource for governments and agencies that are currently implementing or considering food fortification, and a source of information for scientists, technologists and the food industry. The guidelines are written from a nutrition and public health perspective, to provide practical guidance on how food fortification should be implemented, monitored and evaluated. They are primarily intended for nutrition-related public health programme managers, but should also be useful to all those working to control micronutrient malnutrition, including the food industry.
    [Show full text]
  • Antioxidative Effects of A-Tocopherol and Riboflavin-Butyrate in Rats Dosed with Methyl Linoleate Hydroperoxide
    Agric. Biol. Chem., 47 (7), 1577- 1582, 1983 1577 Antioxidative Effects of a-Tocopherol and Riboflavin-butyrate in Rats Dosed with Methyl Linoleate Hydroperoxide Teruo Miyazawa, Chiharu Sato and Takashi Kaneda Department of Food Chemistry, Faculty of Agriculture, Tohoku University, Sendai 980, Japan Received January 6, 1983 The antioxidative effects of dietary a-tocopherol (TOC) and riboftavin-tetrabutyrate (RTB)against tissue lipoperoxidation caused by the long-term administration of methyl linole- ate hydroperoxide (HPO) to rats were investigated by measuring the spontaneous chemilumi- nescence (CL) intensities and thiobarbituric acid (TBA) reactants of the liver, lung and heart. TOCsupplementation resulted in the effective decrease of CLintensities and TBAreac- tants in the three organs, while RTBsupplementation led to the definitive decay of both indices of the lung and a significant decrease in the CL intensity of the heart, as compared with those of rats dosed with HPOand not given any supplemental antioxidant. Although the activities of glutathione peroxidase and glutathione reductase in the three organs obtained from rats dosed with HPOfor 29 days were clearly lower than those of the control rats, both enzyme activities in rats dosed with antioxidants other than HPOwere gener- ally maintained at levels almost equal to those of the control rats. Glutathione peroxidase of the liver and heart and glutathione reductase of the liver were shownto be further activated by the simultaneous supplementation of TOCand RTB. The results indicated that both TOCand RTBeffectively act as antioxidants in rats dosed with HPOover a long-term. Oneof the antioxidative actions of both agents is ascribed to pro- tection of the glutathione peroxidase system in organs undergoing lipoperoxidation caused by the long-term treatment of dietary hydroperoxides.
    [Show full text]
  • Vitamin A, E, & D Unit Change
    Vitamin A, E, & D Unit Change Agenda The following provides an overview of the updated units that NQAC Dublin will be using to adhere to FDA guideline changes regarding Nutrition and Supplement Facts labels. This presentation will review: • FDA Guidelines • Methods Affected • Unit Changes by Vitamin • Conversions In August of 2019, the FDA updated its guideline requirements for Nutrition and Supplement Facts labels regarding vitamin A, vitamin D, and vitamin E. The following link can be used to access the FDA guidelines directly: www.fda.gov/regulatory-information Which methods are affected by this change? • LI-00.608 –Multi Fat • LI-03.701 –Fat Soluble Vitamin Determination in Premixes • LI-00.683- Carotene • GOP-756-1001- Total Vitamin A by Calculation (will be obsoleted) FDA Provided Unit Conversion Table: Vitamin A The previous RDI for vitamin A was expressed in International Units (IU), a measurement based on the biological activity or effect, where one IU of vitamin A activity had been defined as equal to 0.30 mcg of all-trans-retinol or 0.60 mcg of all-trans-β-carotene The new unit of measure, RAE, considers the vitamin A activity of β-carotene in supplements to be half the activity of pre-formed retinol, and the vitamin A activity of dietary β-carotene to be one- sixth of the β-carotene in supplements Furthermore, carotenoids, such as β-carotene, added to food is assumed to have the same bioconversion as those naturally occurring in foods (12:1). For the other dietary provitamin A carotenoids, β-cryptoxanthin and α-carotene, the RAE is set at 24 based on a vitamin A activity approximately half of that for β-carotene.
    [Show full text]
  • Vitamins a and E and Carotenoids
    Fat-Soluble Vitamins & Micronutrients: Vitamins A and E and Carotenoids Vitamins A (retinol) and E (tocopherol) and the carotenoids are fat-soluble micronutrients that are found in many foods, including some vegetables, fruits, meats, and animal products. Fish-liver oils, liver, egg yolks, butter, and cream are known for their higher content of vitamin A. Nuts and seeds are particularly rich sources of vitamin E (Thomas 2006). At least 700 carotenoids—fat-soluble red and yellow pigments—are found in nature (Britton 2004). Americans consume 40–50 of these carotenoids, primarily in fruits and vegetables (Khachik 1992), and smaller amounts in poultry products, including egg yolks, and in seafoods (Boylston 2007). Six major carotenoids are found in human serum: alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein, trans-lycopene, and zeaxanthin. Major carotene sources are orange-colored fruits and vegetables such as carrots, pumpkins, and mangos. Lutein and zeaxanthin are also found in dark green leafy vegetables, where any orange coloring is overshadowed by chlorophyll. Trans-Lycopene is obtained primarily from tomato and tomato products. For information on the carotenoid content of U.S. foods, see the 1998 carotenoid database created by the U.S. Department of Agriculture and the Nutrition Coordinating Center at the University of Minnesota (http://www.nal.usda.gov/fnic/foodcomp/Data/car98/car98.html). Vitamin A, found in foods that come from animal sources, is called preformed vitamin A. Some carotenoids found in colorful fruits and vegetables are called provitamin A; they are metabolized in the body to vitamin A. Among the carotenoids, beta-carotene, a retinol dimer, has the most significant provitamin A activity.
    [Show full text]
  • Niacin (Nicotinic Acid) in Non-Physiological Doses Causes Hyperhomocysteineaemia in Sprague–Dawley Rats
    Downloaded from British Journal of Nutrition (2002), 87, 115–119 DOI: 10.1079/BJN2001486 q The Authors 2002 https://www.cambridge.org/core Niacin (nicotinic acid) in non-physiological doses causes hyperhomocysteineaemia in Sprague–Dawley rats Tapan K. Basu*, Neelam Makhani and Gary Sedgwick . IP address: Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, T6G 2P5 Canada (Received 22 September 2000 – Revised 17 July 2001 – Accepted 6 August 2001) 170.106.35.93 Niacin (nicotinic acid) in its non-physiological dose level is known to be an effective lipid- , on lowering agent; its potential risk as a therapeutic agent, however, has not been critically 27 Sep 2021 at 22:43:08 considered. Since niacin is excreted predominantly as methylated pyridones, requiring methionine as a methyl donor, the present study was undertaken to examine whether metabolism of the amino acid is altered in the presence of large doses of niacin. Male Sprague–Dawley rats were given a nutritionally adequate, semi-synthetic diet containing niacin at a level of either 400 or 1000 mg/kg diet (compared to 30 mg/kg in the control diet) for up to 3 months. Supplementation with niacin (1000 mg/kg diet) for 3 months resulted in a significant increase in plasma and urinary total homocysteine levels; this increase was further accentuated in the , subject to the Cambridge Core terms of use, available at presence of a high methionine diet. The hyperhomocysteineaemia was accompanied by a significant decrease in plasma concentrations of vitamins B6 and B12, which are cofactors for the metabolism of homocysteine.
    [Show full text]
  • Phytochem Referenzsubstanzen
    High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.286. ABIETIC ACID Sylvic acid [514-10-3] 302.46 C20H30O2 01.030. L-ABRINE N-a-Methyl-L-tryptophan [526-31-8] 218.26 C12H14N2O2 Merck Index 11,5 01.031. (+)-ABSCISIC ACID [21293-29-8] 264.33 C15H20O4 Merck Index 11,6 01.032. (+/-)-ABSCISIC ACID ABA; Dormin [14375-45-2] 264.33 C15H20O4 Merck Index 11,6 01.002. ABSINTHIN Absinthiin, Absynthin [1362-42-1] 496,64 C30H40O6 Merck Index 12,8 01.033. ACACETIN 5,7-Dihydroxy-4'-methoxyflavone; Linarigenin [480-44-4] 284.28 C16H12O5 Merck Index 11,9 01.287. ACACETIN Apigenin-4´methylester [480-44-4] 284.28 C16H12O5 01.034. ACACETIN-7-NEOHESPERIDOSIDE Fortunellin [20633-93-6] 610.60 C28H32O14 01.035. ACACETIN-7-RUTINOSIDE Linarin [480-36-4] 592.57 C28H32O14 Merck Index 11,5376 01.036. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- a-D-Glucosamine pentaacetate 389.37 C16H23NO10 ACETYL-a-D-GLUCOPYRANOSE 01.037. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- b-D-Glucosamine pentaacetate [7772-79-4] 389.37 C16H23NO10 ACETYL-b-D-GLUCOPYRANOSE> 01.038. 2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL- Acetochloro-a-D-glucosamine [3068-34-6] 365.77 C14H20ClNO8 a-D-GLUCOPYRANOSYLCHLORIDE - 1 - High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.039.
    [Show full text]
  • Nutrition and Supplement Facts Labels Changes
    NUTRITION AND SUPPLEMENT FACTS LABELS CHANGES The compliance date for these regulations is January 1, 2020 except for businesses with less that $10 million in food sales. These companies have until January 1, 2021. These changes will affect several aspects of current labeling practices and serving sizes. You may have questions concerning these new regulations and what these changes mean to the industry, your company and current practices. Eurofins Food Integrity and Innovation is here to help you answer your questions and, as always, serve as an insightful and resourceful partner to you during this change. General Overview 1. How are daily values changing? The majority of daily values (based on RDI and DRV) are being updated to match recommendations from the National Academy of Science (Institute of Medicine). Changes are listed here for adults and children 4 years of age and older, based on a 2000-calorie diet, as applicable. There are also changes to the daily values for infants, children 1 to 3 and pregnant and lactating women. The components that have a new unit of measure are in bold below: Component Expiring Daily Value New Daily Value Component Expiring Daily Value New Daily Value Fat 65 g 78 g Folate 400 mcg 400 mcg DFE Total Carbohydrate 300 g 275 g Vitamin B12 6 mcg 2.4 mcg Sodium 2400 mg 2300 mg Biotin 300 mcg 30 mcg Dietary Fiber 25 g 28 g Pantothenic acid 10 mg 5 mg Added Sugar 50 g Phosphorous 1000 mg 1250 mg Vitamin A 5000 IU 900 mcg RAE Magnesium 400 mg 420 mg Vitamin C 60 mg 90 mg Zinc 15 mg 11 mg Calcium 1000 mg 1300 mg Selenium 70 mcg 55 mcg Vitamin D 400 IU 20 mcg Copper 2 mg 0.9 mg Vitamin E 30 IU 15 mg Manganese 2 mg 2.3 mg Vitamin K 80 mcg 120 mcg Chromium 120 mcg 35 mcg Thiamin 1.5 mg 1.2 mg Molybdenum 75 mcg 45 mcg Riboflavin 1.7 mg 1.3 mg Chloride 3400 mg 2300 mg Niacin 20 mg 16 mg NE Potassium 3500 mg 4700 mg Vitamin B6 2 mg 1.7 mg Choline 550 mg www.eurofinsUS.com/food NUTRITION AND SUPPLEMENT FACTS LABELS CHANGES 2.
    [Show full text]
  • Adverse Effects of Antioxidative Vitamins
    REVIEW PAPERS International Journal of Occupational Medicine and Environmental Health 2012;25(2):105 – 121 DOI 10.2478/S13382-012-0022-x ADVERSE EFFECTS OF ANTIOXIDATIVE VITAMINS MACIEJ RUTKOWSKI1 and KRZYSZTOF GRZEGORCZYK2 1 Medical University of Łódź, Łódź, Poland Department of Clinical Chemistry and Biochemistry 2 Wł. Biegański Memorial Regional Specialistic Hospital, Łódź, Poland Department of Endoscopy and One Day Gastroenterology Abstract High doses of synthetic antioxidative vitamins: A, E, C and β-carotene are often used on long-term basis in numerous preventive and therapeutic medical applications. Instead of expected health effects, the use of those vitamins may however lead to cases of hypervitaminosis and even to intoxication. The article points out main principles of safety which are to be observed during supplementation with antioxidative vitamins. Toxic effects resulting from erroneous administration of high doses of those substances on organs and systems of the organism are also discussed. Attention is drawn to interactions of antioxidative vitamins with concomitantly used drugs, as well as intensification of adverse effects caused by various exo- genous chemical factors. Moreover, the article presents the evaluation of supplementation with these vitamins, which was performed in large studies. Key words: Vitamins A, E and C, β-carotene, Supplementation, Side actions, Toxic effects INTRODUCTION pharmaceutical drugs, and their preparations are gener- ally sold over the counter. However, it is commonly disre- Supplementation with synthetic antioxidative vitamins: garded that the excessive intake of antioxidative vitamins A, β-carotene (provitamin A), E and C, is widely propa- may be in fact harmful. Enthusiasts of at-home vitamin gated to-day, both as an adjunct to the applied pharma- supplementation, who blindly believe in newspaper rev- cotherapy and as one of factors to provide ”health and elations and advertisements, are therefore vulnerable to beauty”.
    [Show full text]
  • Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy: A
    1 NEUROPROTECTION BY TOCOTRIENOLS IN TYPE 1 2 AND TYPE 2 DIABETES MELLITUS “VENUS” 3 4 5 Protocol no: VENUS Version 18 6 7 8 Project Leader: Prof Dr Yuen Kah Hay, B. Pharm (Hons), Ph. D 9 School of Pharmaceutical Sciences, 10 Universiti Sains Malaysia 11 12 Co-Project Leader: Dr Looi Irene, MBBS (UM), MRCP (UK) 13 Consultant Neurologist 14 Hospital Seberang Jaya, Pulau Pinang 15 16 Team Members: 17 18 Universiti Sains Malaysia 19 Prof Dr Syed Azhar Syed Sulaiman 20 Prof Dr Ibrahim Lutfi Shuaib 21 Dr Nurzalina Abdul Karim Khan 22 Dr Enrico Magosso 23 Assoc Prof Dr Wan Ahmad Kamil Wan Abdullah 24 Hafsa S Najim 25 Choon Wai Yee 26 Lim Sheau Chin 27 Lim Luen Hui 28 Kam Li Ying 29 30 MOH-CRC 31 Dr Ang Hock Aun 32 Dr Ong Loke Meng 33 Dr Yeoh Chin Aun 34 Mr Mak Wen Yao 35 36 Hovid Bhd 37 Dr Wong Jia Woei 38 39 External Monitors 40 Dr Cheah Phaik Yeong - University of Oxford 41 Assoc Prof Dr Mohd Azmi Ahmad Hassali - Universiti Sains Malaysia 42 Dr Asrul Akmal Shafie - Universiti Sains Malaysia 43 44 45 46 47 2012 48 Downloaded From: https://jamanetwork.com/ on 09/28/2021 49 Table of Contents 50 51 Page 52 1. Introduction..................................................................................................................3 53 54 55 2. Aims and Objectives...................................................................................................7 56 57 58 3. Outcomes.....................................................................................................................7 59 60 61 4. Study Design...............................................................................................................8
    [Show full text]
  • The Effect of Combined Treatment of Alpha-Tocopherol, Ascorbic Acid, and Pyridoxine with NMDA Blocker Memantine on Penicillin-Induced Epileptiform Activity in Rats
    Turkish Journal of Medical Sciences Turk J Med Sci (2013) 43: 245-250 http://journals.tubitak.gov.tr/medical/ © TÜBİTAK Research Article doi:10.3906/sag-1204-7 The effect of combined treatment of alpha-tocopherol, ascorbic acid, and pyridoxine with NMDA blocker memantine on penicillin-induced epileptiform activity in rats 1, 2 3 3 Duygu AYDIN *, Mehmet YILDIRIM , Mustafa AYYILDIZ , Erdal AĞAR 1 Department of Physiology, Faculty of Medicine, Turgut Özal University, Ankara, Turkey 2 Department of Physiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey 3 Department of Physiology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey Received: 02.04.2012 Accepted: 25.05.2012 Published Online: 15.03.2013 Printed: 15.04.2013 Aim: To evaluate the effects of coadministration of vitamins alpha-tocopherol, ascorbic acid, and pyridoxine with memantine on a penicillin-induced experimental epilepsy model in rats so as to clarify the eventual interaction between these vitamins and the N-methyl- D-aspartate (NMDA) system. Materials and methods: The epileptic focus was produced by intracortical penicillin G potassium injection. The effects of intraperitoneal injections of memantine, memantine + alpha-tocopherol, memantine + ascorbic acid, and memantine + pyridoxine combinations on epileptiform activity were evaluated in electrocorticogram recordings. Results: The antiepileptiform effects appeared earlier in all memantine and vitamin coadministrated groups compared to the memantine-alone group, but the difference between the groups was not statistically significant considering the frequency and amplitude of the epileptiform activity. Conclusion: Coadministration of vitamins does not enhance the antiepileptiform activity of memantine in penicillin-induced epilepsy in rats. However, this coadministration causes the earlier appearance of antiseizure effects.
    [Show full text]